Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: A case–control study

References

• European Centre for Disease Prevention and Control. Surveillance report: Tuberculosis surveillance in Europe 2009. Available at: http://www.ecdc.europa.eu/en/publications/Publications/1103 Tuberculosis surveillance in Europe 2009.pdf (accessed on 14 June 2011).
   Google Scholar
• Robert Koch-Institut. Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2009. Available at: http://www.rki.de/cln_178/nn_274324/DE/Content/InfAZ/T/Tuberkulose/Download/TB2009,templateId = raw,property = publicationFile.pdf/TB2009.pdf (accessed on 26 April 2011).
   Google Scholar
• Kunitz F, Brodhun B, Hauer B, Haas W, Loddenkemper R. The current status of tuberculosis in Germany and impact of the global situation. Pneumologie 2007;61:467–77.
   PubMedGoogle Scholar
• Cruz AT, Starke JR. Pediatric tuberculosis. Pediatr Rev 2010;21:13–26.
   Google Scholar
• Haimi-Cohen Y, Zeharia A, Mimouni M, Soukhman M, Amir J. Skin induration in response to tuberculin testing in patients with nontuberculous mycobacterial lymphadenitis. Clin Infect Dis 2001;33:1786–8.
   PubMedGoogle Scholar
• Magdorf K, Detjen AK. Proposed management of childhood tuberculosis in low-incidence countries. Eur J Pediatr 2009; 167:927–38.
   Google Scholar
• Rolinck-Werninghaus C, Magdorf K, Stark K, Lyashchenko K, Gennaro ML, Colangeli R, . The potential of recombinant antigens ESAT-6, MPT63 and mig for specific discrimination of Mycobacterium tuberculosis and M. avium infection. Eur J Pediatr 2003;162:534–6.
   PubMedGoogle Scholar
• Pai M, Zwerling A, Menzies D. Systematic review: T-Cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177–84.
   PubMed Web of Science ®Google Scholar
• Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A. Negative and positive predictive value of a whole-blood interferon-gamma release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med 2011;183:88–95.
   PubMed Web of Science ®Google Scholar
• Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 2011 Jun 8. [Epub ahead of print]
   Google Scholar
• Kampmann B, Whittaker E, Williams A, Walters S, Gordon A, Martinez-Alier N, . Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur Respir J 2009;33:1374–82.
   PubMed Web of Science ®Google Scholar
• Zrinski Topić R, Zoričić-Letoja I, Pavić I, Dodig S. Indeterminate results of QuantiFERON-TB Gold In-Tube assay in nonimmunosuppressed children. Arch Med Res 2011;42:138–43.
   PubMedGoogle Scholar
• Connel TG, Tebruegge M, Ritz N, Bryant PA, Leslie D, Curtis N. Indeterminate interferon-γ release assay results in children. Pediatr Infect Dis J 2010;29:285–6.
   PubMedGoogle Scholar
• Haustein T, Ridout DA, Hartley JC, Thaker U, Shingadia D, Klein NJ, . The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J 2009;28:669–73.
   PubMed Web of Science ®Google Scholar
• Lalvani A, Millington KA. T cell-based diagnosis of childhood tuberculosis infection. Curr Opin Infect Dis 2007;20:264–71.
   PubMed Web of Science ®Google Scholar
• Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 2011;98:207–15.
   Google Scholar
• Ruhwald M, Ravn P. Biomarkers of latent TB infection. Expert Rev Resp Med 2009;3:387–401.
   PubMedGoogle Scholar
• Lighter J, Rigaud M, Huie M, Peng CH, Pollack H. Chemokine IP-10: an adjunct marker for latent tuberculosis infection in children. Int J Tuberc Lung Dis 2009;13:731–6.
   PubMed Web of Science ®Google Scholar
• Whittaker E, Gordon A, Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFN-γ. PLoS One 2008;3:e3901.
   PubMed Web of Science ®Google Scholar
• Petrucci R, Abu Amer N, Gurgel RQ, Sherchand JB, Doria L, Lama C, . Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Pediatr Infect Dis J 2008;27:1073–7.
   PubMedGoogle Scholar
• Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, Ravn P. IP-10/CXCL10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP-10 and TB7. 7. Microbes Infect 2007;9:806–12.
   PubMed Web of Science ®Google Scholar
• Ruhwald M, Petersen J, Kofoed K, Nakaoka H, Cuevas LE, Lawson L, . Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One 2008;3:e2858.
   PubMed Web of Science ®Google Scholar
• Syed Ahamed Kabeer B, Raman B, Thomas A, Perumal V, Raja A. Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One 2010;5:e9051.
   PubMedGoogle Scholar
• Goletti D, Raja A, Syed Ahamed Kabeer B, Rodrigues C, Sodha A, Carrara S, . Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS One 2010;5:e12577.
   Google Scholar
• Aabye MG, Ruhwald M, Praygod G, Jeremiah K, Faurholt-Jepsen M, Faurholt-Jepsen D, . Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients. Eur Respir J 2010;36:1488–90.
   PubMed Web of Science ®Google Scholar
• Garg RK. Tuberculous meningitis. Acta Neurol Scand 2010;122:75–90.
   PubMed Web of Science ®Google Scholar
• Ruhwald M, Bjerregaard-Andersen M, Rabna P, Eugen-Olsen J, Ravn P. IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay. BMC Res Notes 2009;2:19.
   Google Scholar
• Chegou NN, Black GF, Kidd M, van Helden PD, Walzl G. Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med 2009;9:21.
   PubMedGoogle Scholar
• Gangur V, Simons FE, Hayglass KT. Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFN-gamma over IL-4 responses. FASEB J 1998;12:705–13.
   PubMed Web of Science ®Google Scholar
• Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011;37:100–11.
   PubMed Web of Science ®Google Scholar
• QuantiFERON-TB gold in-tube precision and reproducibility report. Cellestis; Available at: http://www.cellestis.com/IRM/content/gold/Precisionproductivity.pdf (accessed on 20 June 2011).
   Google Scholar
• Lewinsohn DA, Lobato MN, Jereb JA. Interferon-γ release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children. Curr Opin Pediatr 2010;22:71–6.
   PubMedGoogle Scholar
• Ling DI, Zwerling AA, Steingart KR, Pai M. Immune-based diagnostics for TB in children: what is the evidence? Paediatr Respir Rev 2011;12:9–15.
   PubMed Web of Science ®Google Scholar
• Kabeer BS, Raja A, Raman B, Thangaraj S, Leportier M, Ippolito G, . IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy. BMC Infect Dis 2011;11:135.
   PubMedGoogle Scholar
• Reuss AM, Wiese-Posselt M, Weissmann B, Siedler A, Zuschneid I, An der Heiden M, . Incidence rate of nontuberculous mycobacterial disease in immunocompetent children: a prospective nationwide surveillance study in Germany. Pediatr Infect Dis J 2009;28:642–4.
   PubMed Web of Science ®Google Scholar